William H. Sharfman
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 66
- Cancer Immunotherapy and Biomarkers 44
- CAR-T cell therapy research 26
- Colorectal Cancer Treatments and Studies 8
- Polyomavirus and related diseases 7
- Immunology 24
- Immunotherapy and Immune Responses 18
- Immune Cell Function and Interaction 7
- Co-authors
- Suzanne L. Topalian (24 shared papers)Janis M. Taube (11 shared papers)Julie R. Brahmer (8 shared papers)Drew M. Pardoll (7 shared papers)Robert A. Anders (6 shared papers)Charles G. Drake (3 shared papers)Lieping Chen (3 shared papers)Ira Wollner (3 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Annals of Oncology (5 papers)Journal for ImmunoTherapy of Cancer (5 papers)Cancer (3 papers)JNCI Journal of the National Cancer Institute (3 papers)
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
William H. Sharfman
81 papers receiving 6.0k citations
William H. Sharfman's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 4.6k
- Immunology 2.0k
- Pulmonary and Respiratory Medicine 1.3k
- Otorhinolaryngology 130
- Genetics 314
Countries citing papers authored by William H. Sharfman
This map shows the geographic impact of William H. Sharfman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Sharfman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Sharfman more than expected).
Fields of papers citing papers by William H. Sharfman
This network shows the impact of papers produced by William H. Sharfman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Sharfman. The network helps show where William H. Sharfman may publish in the future.
Co-authors
The 25 scholars most cited alongside William H. Sharfman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates Hit paper breakdown → | 2010 | 2331 |
| 2 | 2012 | 425 | |
| 3 | 2017 | 245 | |
| 4 | 2017 | 205 | |
| 5 | 2017 | 167 | |
| 6 | 2011 | 156 | |
| 7 | 2010 | 150 | |
| 8 | 2013 | 143 | |
| 9 | 1992 | 136 | |
| 10 | 2021 | 126 | |
| 11 | 2014 | 121 | |
| 12 | 2017 | 115 | |
| 13 | 2017 | 110 | |
| 14 | 2014 | 100 | |
| 15 | 1993 | 98 | |
| 16 | 2018 | 78 | |
| 17 | 2015 | 73 | |
| 18 | 1990 | 71 | |
| 19 | Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. | 1997 | 64 |
| 20 | 1992 | 63 |
About William H. Sharfman
William H. Sharfman is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 82 papers that have together received 6.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (44 papers), CAR-T cell therapy research (26 papers), Immunotherapy and Immune Responses (18 papers), Melanoma and MAPK Pathways (12 papers), Brain Metastases and Treatment (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Immune Cell Function and Interaction (7 papers) and Polyomavirus and related diseases (7 papers). The work is most often cited by research in Oncology (4.6k citations), Immunology (2.0k citations), Pulmonary and Respiratory Medicine (1.3k citations), Otorhinolaryngology (130 citations) and Genetics (314 citations). William H. Sharfman has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Suzanne L. Topalian, Janis M. Taube, Julie R. Brahmer, Drew M. Pardoll, Robert A. Anders, Charles G. Drake, Lieping Chen, Ira Wollner, Alice Pons and Evan J. Lipson. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal for ImmunoTherapy of Cancer, Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.